Forrester Research Inc. (FORR) Misses Q1 EPS by 1c, Posts Q2 and FY11 Guidance
Tweet
Share
E-mailGet Alerts FORR Hot Sheet
Price: $11.38 -3.48%
Financial Fact:
Diluted weighted average common shares outstanding: 18.15M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Diluted weighted average common shares outstanding: 18.15M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Forrester Research Inc. (NASDAQ: FORR) reported Q1 EPS of $0.21, $0.01 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $65.7 million versus the consensus estimate of $64.27 million.
Forrester Research Inc. sees Q2 2011 EPS of $0.21-$0.25, versus the consensus of $0.37. Forrester Research Inc. sees Q2 2011 revenue of $71.5-$74.5 million, versus the consensus of $72.96 million.
Forrester Research Inc. sees FY2011 EPS of $0.96-$1.02, versus the consensus of $1.28. Forrester Research Inc. sees FY2011 revenue of $282-$288 million, versus the consensus of $283.03 million.
Forrester Research Inc. sees Q2 2011 EPS of $0.21-$0.25, versus the consensus of $0.37. Forrester Research Inc. sees Q2 2011 revenue of $71.5-$74.5 million, versus the consensus of $72.96 million.
Forrester Research Inc. sees FY2011 EPS of $0.96-$1.02, versus the consensus of $1.28. Forrester Research Inc. sees FY2011 revenue of $282-$288 million, versus the consensus of $283.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
